Twist Bioscience Corp (ticker: TWST) is an NASDAQ-listed clinical research company. DredgeCap's structured extraction of TWST's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. TWST reported no tagged revenue in revenue and -$74.53M for the period ending 2026-03-31, with operating cash flow of -$42.37M. Cash and equivalents stood at $122.67M (down 41.7% year-over-year). Total assets of $676.21M exceed total liabilities of $221.12M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
TWST Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Twist Bioscience Corp (TWST) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.